U.S. Court of Appeals for the Federal Circuit, 2024

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.

Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.
U.S. Court of Appeals for the Federal Circuit · Decided September 4, 2024
Alexion Pharmaceuticals, Inc. v. Samsung Bioepis Co. Ltd.

Opinion

Case: 24-1829 Document: 31 Page: 1 Filed: 09/04/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ALEXION PHARMACEUTICALS, INC., ALEXION PHARMA INTERNATIONAL OPERATIONS

LTD.,

Plaintiffs-Appellants v.

SAMSUNG BIOEPIS CO. LTD.,

Defendant-Appellee ______________________

2024-1829 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:24-cv-00005-GBW, Judge Gregory Brian Williams. ______________________

ORDER

The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 24-1829 Document: 31 Page: 2 Filed: 09/04/2024

2 ALEXION PHARMACEUTICALS, INC. V. SAMSUNG BIOEPIS CO. LTD.

(2) Each side shall bear their own costs.

FOR THE COURT

September 4, 2024

Date

ISSUED AS A MANDATE: September 4, 2024

Case-law data current through September 30, 2026. Source: CourtListener bulk data.